|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/00 | |
| A61K 31/395 | |||
| A61K 31/165 | |||
| A61P 7/06 |
| (11) | Number of the document | 1633333 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04754383.0 |
| Date of filing the European patent application | 2004-06-04 | |
| (97) | Date of publication of the European application | 2006-03-15 |
| (45) | Date of publication and mention of the grant of the patent | 2014-08-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/017772 |
| Date | 2004-06-04 |
| (87) | Number | WO 2004/108121 |
| Date | 2004-12-16 |
| (30) | Number | Date | Country code |
| 476704 P | 2003-06-06 | US | |
| 566488 P | 2004-04-29 | US | |
| 566237 P | 2004-04-29 | US | |
| 569797 P | 2004-05-10 | US | |
| 861590 | 2004-06-03 | US |
| (72) |
KLAUS, Stephen, J., US
MOLINEAUX, Christopher, J., US
NEFF, Thomas, B., US
GUENZLER-PUKALL, Volkmar, US
LANSETMO PAROBOK, Ingrid, US
SEELEY, Todd, W., US
STEPHENSON, Robert, C., US
|
| (73) |
Fibrogen, Inc.,
409 Illinois Street, San Francisco, CA 94158,
US
|
| (54) | USE OF HIF ALPHA STABILIZERS FOR ENHANCING ERYTHROPOIESIS |
| USE OF HIF ALPHA STABILIZERS FOR ENHANCING ERYTHROPOIESIS |